ArticleOncotarget2021
A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection.
Shay Sharon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleOncotarget2021
Shay Sharon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.